Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

What were the most important lessons in Life Sciences in 2019?

Posted on December 20th, 2019 by in Pharma R&D

As 2019 comes to a close, we asked members of Elsevier’s Life Sciences team:

What were the biggest lessons or most noteworthy developments in the Life Sciences industry this year?

(more…)

Machine Learning Could Make Drug Discovery Faster, Cheaper, Better

Posted on November 6th, 2018 by in Pharma R&D

The stats on the increasingly high cost (and low success rates) in drug discovery are always jarring. As Phee Waterfield of Binary District Journal reports:

  • Bringing a new drug to market is estimated to cost major pharma firms more than $4 billion
  • The process can take 10-15 years
  • Fewer than 10% actually make it to market

(more…)

Big Talks on Big Data are Coming to Bio IT World

Posted on May 9th, 2018 by in Pharma R&D

At next week’s Bio IT World conference and expo (Boston, May 15-17), Elsevier will be giving four talks on the implications of AI and machine learning on life science research, a statistical analysis of concordance between animal toxicities and human adverse events, strategies for increasing data sharing and the latest technologies being used to integrate multiple data sources. (more…)

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by in Pharma R&D

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. (more…)

  1. 1
  2. 2
  3. 3
  4. 6